{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T23:21:40Z","timestamp":1794871300760,"version":"4.9.1"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"7815","license":[{"start":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T00:00:00Z","timestamp":1589760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T00:00:00Z","timestamp":1589760000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2020,7,9]]},"DOI":"10.1038\/s41586-020-2349-y","type":"journal-article","created":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T06:02:50Z","timestamp":1589781770000},"page":"290-295","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2002,"title":["Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody"],"prefix":"10.1038","volume":"583","author":[{"given":"Dora","family":"Pinto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Jun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Beltramello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra C.","family":"Walls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2260-2577","authenticated-orcid":false,"given":"M. Alejandra","family":"Tortorici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5100-8905","authenticated-orcid":false,"given":"Siro","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Jaconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0956-0018","authenticated-orcid":false,"given":"Katja","family":"Culap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizia","family":"Zatta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"De Marco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Peter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Guarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Spreafico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Cameroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7331-5511","authenticated-orcid":false,"given":"James Brett","family":"Case","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita E.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2880-3927","authenticated-orcid":false,"given":"Colin","family":"Havenar-Daughton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyorgy","family":"Snell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amalio","family":"Telenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert W.","family":"Virgin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Lanzavecchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Diamond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Fink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6019-8675","authenticated-orcid":false,"given":"David","family":"Veesler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5797-1364","authenticated-orcid":false,"given":"Davide","family":"Corti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,18]]},"reference":[{"key":"2349_CR1","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","volume":"579","author":"P Zhou","year":"2020","unstructured":"Zhou, P. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579, 270\u2013273 (2020).","journal-title":"Nature"},{"key":"2349_CR2","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","volume":"382","author":"N Zhu","year":"2020","unstructured":"Zhu, N. et al. A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. 382, 727\u2013733 (2020).","journal-title":"N. Engl. J. Med."},{"key":"2349_CR3","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/bs.aivir.2019.08.002","volume":"105","author":"MA Tortorici","year":"2019","unstructured":"Tortorici, M. A. & Veesler, D. Structural insights into coronavirus entry. Adv. Virus Res. 105, 93\u2013116 (2019).","journal-title":"Adv. Virus Res."},{"key":"2349_CR4","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/nature16988","volume":"531","author":"AC Walls","year":"2016","unstructured":"Walls, A. C. et al. Cryo-electron microscopy structure of a coronavirus spike glycoprotein trimer. Nature 531, 114\u2013117 (2016).","journal-title":"Nature"},{"key":"2349_CR5","doi-asserted-by":"crossref","first-page":"11157","DOI":"10.1073\/pnas.1708727114","volume":"114","author":"AC Walls","year":"2017","unstructured":"Walls, A. C. et al. Tectonic conformational changes of a coronavirus spike glycoprotein promote membrane fusion. Proc. Natl Acad. Sci. USA 114, 11157\u201311162 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2349_CR6","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","volume":"181","author":"AC Walls","year":"2020","unstructured":"Walls, A. C. et al. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell 181, 281\u2013292.e6 (2020).","journal-title":"Cell"},{"key":"2349_CR7","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann, M. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181, 271\u2013280.e8 (2020).","journal-title":"Cell"},{"key":"2349_CR8","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/s41564-020-0688-y","volume":"5","author":"M Letko","year":"2020","unstructured":"Letko, M., Marzi, A. & Munster, V. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat. Microbiol. 5, 562\u2013569 (2020).","journal-title":"Nat. Microbiol."},{"key":"2349_CR9","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","volume":"367","author":"D Wrapp","year":"2020","unstructured":"Wrapp, D. et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science 367, 1260\u20131263 (2020).","journal-title":"Science"},{"key":"2349_CR10","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1038\/sj.emboj.7600640","volume":"24","author":"W Li","year":"2005","unstructured":"Li, W. et al. Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2. EMBO J. 24, 1634\u20131643 (2005).","journal-title":"EMBO J."},{"key":"2349_CR11","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1128\/JVI.72.1.497-503.1998","volume":"72","author":"JW Rossen","year":"1998","unstructured":"Rossen, J. W. et al. The viral spike protein is not involved in the polarized sorting of coronaviruses in epithelial cells. J. Virol. 72, 497\u2013503 (1998).","journal-title":"J. Virol."},{"key":"2349_CR12","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/nsmb.3293","volume":"23","author":"AC Walls","year":"2016","unstructured":"Walls, A. C. et al. Glycan shield and epitope masking of a coronavirus spike protein observed by cryo-electron microscopy. Nat. Struct. Mol. Biol. 23, 899\u2013905 (2016).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"2349_CR13","doi-asserted-by":"crossref","first-page":"e01628","DOI":"10.1128\/JVI.01628-17","volume":"92","author":"X Xiong","year":"2018","unstructured":"Xiong, X. et al. Glycan shield and fusion activation of a deltacoronavirus spike glycoprotein fine-tuned for enteric infections. J. Virol. 92, e01628-17 (2018).","journal-title":"J. Virol."},{"key":"2349_CR14","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.cell.2018.12.028","volume":"176","author":"AC Walls","year":"2019","unstructured":"Walls, A. C. et al. Unexpected receptor functional mimicry elucidates activation of coronavirus fusion. Cell 176, 1026\u20131039 (2019).","journal-title":"Cell"},{"key":"2349_CR15","doi-asserted-by":"crossref","first-page":"9119","DOI":"10.1128\/JVI.01279-15","volume":"89","author":"Y Yang","year":"2015","unstructured":"Yang, Y. et al. Two mutations were critical for bat-to-human transmission of Middle East respiratory syndrome coronavirus. J. Virol. 89, 9119\u20139123 (2015).","journal-title":"J. Virol."},{"key":"2349_CR16","doi-asserted-by":"publisher","DOI":"10.1126\/science.abb9983","author":"Y Watanabe","year":"2020","unstructured":"Watanabe, Y., Allen, J. D., Wrapp, D., McLellan, J. S. & Crispin, M. Site-specific analysis of the SARS-CoV-2 glycan spike. Science https:\/\/doi.org\/10.1126\/science.abb9983 (2020).","journal-title":"Science"},{"key":"2349_CR17","doi-asserted-by":"crossref","first-page":"E7348","DOI":"10.1073\/pnas.1707304114","volume":"114","author":"J Pallesen","year":"2017","unstructured":"Pallesen, J. et al. Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen. Proc. Natl Acad. Sci. USA 114, E7348\u2013E7357 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2349_CR18","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1126\/science.abb2762","volume":"367","author":"R Yan","year":"2020","unstructured":"Yan, R. et al. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science 367, 1444\u20131448 (2020).","journal-title":"Science"},{"key":"2349_CR19","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41586-020-2179-y","volume":"581","author":"J Shang","year":"2020","unstructured":"Shang, J. et al. Structural basis of receptor recognition by SARS-CoV-2. Nature 581, 221\u2013224 (2020).","journal-title":"Nature"},{"key":"2349_CR20","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","volume":"581","author":"J Lan","year":"2020","unstructured":"Lan, J. et al. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature 581, 215\u2013220 (2020).","journal-title":"Nature"},{"key":"2349_CR21","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/s41587-020-0512-5","volume":"38","author":"B Kelley","year":"2020","unstructured":"Kelley, B. Developing therapeutic monoclonal antibodies at pandemic pace. Nat. Biotechnol. 38, 540\u2013545 (2020).","journal-title":"Nat. Biotechnol."},{"key":"2349_CR22","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1126\/science.aad5224","volume":"351","author":"D Corti","year":"2016","unstructured":"Corti, D. et al. Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody. Science 351, 1339\u20131342 (2016).","journal-title":"Science"},{"key":"2349_CR23","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1056\/NEJMe1915350","volume":"381","author":"MM Levine","year":"2019","unstructured":"Levine, M. M. Monoclonal antibody therapy for Ebola virus disease. N. Engl. J. Med. 381, 2365\u20132366 (2019).","journal-title":"N. Engl. J. Med."},{"key":"2349_CR24","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/nm1080","volume":"10","author":"E Traggiai","year":"2004","unstructured":"Traggiai, E. et al. An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus. Nat. Med. 10, 871\u2013875 (2004).","journal-title":"Nat. Med."},{"key":"2349_CR25","doi-asserted-by":"crossref","first-page":"10473","DOI":"10.1073\/pnas.1510199112","volume":"112","author":"D Corti","year":"2015","unstructured":"Corti, D. et al. Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus. Proc. Natl Acad. Sci. USA 112, 10473\u201310478 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2349_CR26","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1128\/JVI.02377-07","volume":"82","author":"B Rockx","year":"2008","unstructured":"Rockx, B. et al. Structural basis for potent cross-neutralizing human monoclonal antibody protection against lethal human and zoonotic severe acute respiratory syndrome coronavirus challenge. J. Virol. 82, 3220\u20133235 (2008).","journal-title":"J. Virol."},{"key":"2349_CR27","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1073\/pnas.1517719113","volume":"113","author":"VD Menachery","year":"2016","unstructured":"Menachery, V. D. et al. SARS-like WIV1-CoV poised for human emergence. Proc. Natl Acad. Sci. USA 113, 3048\u20133053 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2349_CR28","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1126\/science.abb7269","volume":"368","author":"M Yuan","year":"2020","unstructured":"Yuan, M. et al. A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV. Science 368, 630\u2013633 (2020).","journal-title":"Science"},{"key":"2349_CR29","doi-asserted-by":"publisher","unstructured":"Joyce, M. G. et al. A cryptic site of vulnerability on the receptor binding domain of the SARS-CoV-2 spike glycoprotein. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2020.03.15.992883\u00a0(2020).","DOI":"10.1101\/2020.03.15.992883"},{"key":"2349_CR30","volume":"11","author":"C Wang","year":"2020","unstructured":"Wang, C. et al. A human monoclonal antibody blocking SARS-CoV-2 infection. Nat. Commun. 11, 2251 (2020).","journal-title":"Nat. Commun."},{"key":"2349_CR31","doi-asserted-by":"publisher","unstructured":"Ju, B., Zhang, Q., Ge, J. et al. Human neutralizing antibodies elicited by SARS-CoV-2 infection. Nature https:\/\/doi.org\/10.1038\/s41586-020-2380-z (2020).","DOI":"10.1038\/s41586-020-2380-z"},{"key":"2349_CR32","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1086\/651022","volume":"201","author":"B Rockx","year":"2010","unstructured":"Rockx, B. et al. Escape from human monoclonal antibody neutralization affects in vitro and in vivo fitness of severe acute respiratory syndrome coronavirus. J. Infect. Dis. 201, 946\u2013955 (2010).","journal-title":"J. Infect. Dis."},{"key":"2349_CR33","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/s41594-019-0233-y","volume":"26","author":"MA Tortorici","year":"2019","unstructured":"Tortorici, M. A. et al. Structural basis for human coronavirus attachment to sialic acid receptors. Nat. Struct. Mol. Biol. 26, 481\u2013489 (2019).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"2349_CR34","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/s41594-019-0334-7","volume":"26","author":"YJ Park","year":"2019","unstructured":"Park, Y. J. et al. Structures of MERS-CoV spike glycoprotein in complex with sialoside attachment receptors. Nat. Struct. Mol. Biol. 26, 1151\u20131157 (2019).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"2349_CR35","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.cell.2018.12.028","volume":"176","author":"AC Walls","year":"2019","unstructured":"Walls, A. C. et al. Unexpected receptor functional mimicry elucidates activation of coronavirus fusion. Cell 176, 1026\u20131039.e15 (2019).","journal-title":"Cell"},{"key":"2349_CR36","doi-asserted-by":"publisher","unstructured":"Liu, C. et al. Viral architecture of SARS-CoV-2 with post-fusion spike revealed by cryo-EM. Preprint bioRxiv https:\/\/doi.org\/10.1101\/2020.03.02.972927\u00a0(2020).","DOI":"10.1101\/2020.03.02.972927"},{"key":"2349_CR37","first-page":"e2035","volume":"6","author":"JK Millet","year":"2016","unstructured":"Millet, J. K. & Whittaker, G. R. Murine leukemia virus (MLV)-based coronavirus spike-pseudotyped particle production and infection. Bio. Protoc. 6, e2035 (2016).","journal-title":"Bio. Protoc."},{"key":"2349_CR38","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nature12711","volume":"503","author":"XY Ge","year":"2013","unstructured":"Ge, X. Y. et al. Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor. Nature 503, 535\u2013538 (2013).","journal-title":"Nature"},{"key":"2349_CR39","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","volume":"395","author":"R Lu","year":"2020","unstructured":"Lu, R. et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 395, 565\u2013574 (2020).","journal-title":"Lancet"},{"key":"2349_CR40","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/jmv.25701","volume":"92","author":"X Li","year":"2020","unstructured":"Li, X. et al. Transmission dynamics and evolutionary history of 2019-nCoV. J. Med. Virol. 92, 501\u2013511 (2020).","journal-title":"J. Med. Virol."},{"key":"2349_CR41","unstructured":"Pond, S. SARS-CoV-2 Natural Selection Analysis. http:\/\/data.hyphy.org\/web\/covid-19\/dashboard\/ (2020)."},{"key":"2349_CR42","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1146\/annurev-virology-031413-085507","volume":"1","author":"EC Smith","year":"2014","unstructured":"Smith, E. C., Sexton, N. R. & Denison, M. R. Thinking outside the triangle: replication fidelity of the largest RNA viruses. Annu. Rev. Virol. 1, 111\u2013132 (2014).","journal-title":"Annu. Rev. Virol."},{"key":"2349_CR43","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1126\/science.1116480","volume":"309","author":"F Li","year":"2005","unstructured":"Li, F., Li, W., Farzan, M. & Harrison, S. C. Structure of SARS coronavirus spike receptor-binding domain complexed with receptor. Science 309, 1864\u20131868 (2005).","journal-title":"Science"},{"key":"2349_CR44","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1099\/0022-1317-83-9-2091","volume":"83","author":"PJ Klasse","year":"2002","unstructured":"Klasse, P. J. & Sattentau, Q. J. Occupancy and mechanism in antibody-mediated neutralization of animal viruses. J. Gen. Virol. 83, 2091\u20132108 (2002).","journal-title":"J. Gen. Virol."},{"key":"2349_CR45","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s13238-017-0473-8","volume":"9","author":"X Wang","year":"2018","unstructured":"Wang, X., Mathieu, M. & Brezski, R. J. IgG Fc engineering to modulate antibody effector functions. Protein Cell 9, 63\u201373 (2018).","journal-title":"Protein Cell"},{"key":"2349_CR46","volume":"8","author":"W He","year":"2017","unstructured":"He, W. et al. Alveolar macrophages are critical for broadly-reactive antibody-mediated protection against influenza A virus in mice. Nat. Commun. 8, 846 (2017).","journal-title":"Nat. Commun."},{"key":"2349_CR47","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.cell.2015.04.016","volume":"161","author":"DJ DiLillo","year":"2015","unstructured":"DiLillo, D. J. & Ravetch, J. V. Differential Fc\u2013receptor engagement drives an anti-tumor vaccinal effect. Cell 161, 1035\u20131045 (2015).","journal-title":"Cell"},{"key":"2349_CR48","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1126\/science.1205669","volume":"333","author":"D Corti","year":"2011","unstructured":"Corti, D. et al. A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins. Science 333, 850\u2013856 (2011).","journal-title":"Science"},{"key":"2349_CR49","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature06106","volume":"449","author":"AJ Hessell","year":"2007","unstructured":"Hessell, A. J. et al. Fc receptor but not complement binding is important in antibody protection against HIV. Nature 449, 101\u2013104 (2007).","journal-title":"Nature"},{"key":"2349_CR50","doi-asserted-by":"crossref","unstructured":"Iwasaki, A. & Yang, Y. The potential danger of suboptimal antibody responses in COVID-19. Nat. Rev. Immunol.\u00a020, 339\u2013341 (2020).","DOI":"10.1038\/s41577-020-0321-6"},{"key":"2349_CR51","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1017\/S0022172400062410","volume":"95","author":"KA Callow","year":"1985","unstructured":"Callow, K. A. Effect of specific humoral immunity and some non-specific factors on resistance of volunteers to respiratory coronavirus infection. J. Hyg. (Lond.) 95, 173\u2013189 (1985).","journal-title":"J. Hyg. (Lond.)"},{"key":"2349_CR52","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/jmv.1890130208","volume":"13","author":"SE Reed","year":"1984","unstructured":"Reed, S. E. The behaviour of recent isolates of human respiratory coronavirus in vitro and in volunteers: evidence of heterogeneity among 229E-related strains. J. Med. Virol. 13, 179\u2013192 (1984).","journal-title":"J. Med. Virol."},{"key":"2349_CR53","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1017\/S0950268800048019","volume":"105","author":"KA Callow","year":"1990","unstructured":"Callow, K. A., Parry, H. F., Sergeant, M. & Tyrrell, D. A. The time course of the immune response to experimental coronavirus infection of man. Epidemiol. Infect. 105, 435\u2013446 (1990).","journal-title":"Epidemiol. Infect."},{"key":"2349_CR54","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1371\/journal.pmed.0030237","volume":"3","author":"J ter Meulen","year":"2006","unstructured":"ter Meulen, J. et al. Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants. PLoS Med. 3, e237 (2006).","journal-title":"PLoS Med."},{"key":"2349_CR55","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.aaf8505","volume":"353","author":"K Stettler","year":"2016","unstructured":"Stettler, K. et al. Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection. Science 353, 823\u2013826 (2016).","journal-title":"Science"},{"key":"2349_CR56","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nbt.1601","volume":"28","author":"J Zalevsky","year":"2010","unstructured":"Zalevsky, J. et al. Enhanced antibody half-life improves in vivo activity. Nat. Biotechnol. 28, 157\u2013159 (2010).","journal-title":"Nat. Biotechnol."},{"key":"2349_CR57","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1080\/22221751.2020.1729069","volume":"9","author":"X Tian","year":"2020","unstructured":"Tian, X. et al. Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody. Emerg. Microbes Infect. 9, 382\u2013385 (2020).","journal-title":"Emerg. Microbes Infect."},{"key":"2349_CR58","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jsb.2005.03.010","volume":"151","author":"C Suloway","year":"2005","unstructured":"Suloway, C. et al. Automated molecular microscopy: the new Leginon system. J. Struct. Biol. 151, 41\u201360 (2005).","journal-title":"J. Struct. Biol."},{"key":"2349_CR59","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/nmeth.4347","volume":"14","author":"YZ Tan","year":"2017","unstructured":"Tan, Y. Z. et al. Addressing preferred specimen orientation in single-particle cryo-EM through tilting. Nat. Methods 14, 793\u2013796 (2017).","journal-title":"Nat. Methods"},{"key":"2349_CR60","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1038\/s41592-019-0580-y","volume":"16","author":"D Tegunov","year":"2019","unstructured":"Tegunov, D. & Cramer, P. Real-time cryo-electron microscopy data preprocessing with Warp. Nat. Methods 16, 1146\u20131152 (2019).","journal-title":"Nat. Methods"},{"key":"2349_CR61","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nmeth.4169","volume":"14","author":"A Punjani","year":"2017","unstructured":"Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290\u2013296 (2017).","journal-title":"Nat. Methods"},{"key":"2349_CR62","doi-asserted-by":"crossref","first-page":"e42166","DOI":"10.7554\/eLife.42166","volume":"7","author":"J Zivanov","year":"2018","unstructured":"Zivanov, J. et al. New tools for automated high-resolution cryo-EM structure determination in RELION-3. eLife 7, e42166 (2018).","journal-title":"eLife"},{"key":"2349_CR63","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1107\/S205225251801463X","volume":"6","author":"J Zivanov","year":"2019","unstructured":"Zivanov, J., Nakane, T. & Scheres, S. H. W. A Bayesian approach to beam-induced motion correction in cryo-EM single-particle analysis. IUCrJ 6, 5\u201317 (2019).","journal-title":"IUCrJ"},{"key":"2349_CR64","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/nmeth.2115","volume":"9","author":"SH Scheres","year":"2012","unstructured":"Scheres, S. H. & Chen, S. Prevention of overfitting in cryo-EM structure determination. Nat. Methods 9, 853\u2013854 (2012).","journal-title":"Nat. Methods"},{"key":"2349_CR65","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jsb.2006.06.010","volume":"157","author":"TD Goddard","year":"2007","unstructured":"Goddard, T. D., Huang, C. C. & Ferrin, T. E. Visualizing density maps with UCSF Chimera. J. Struct. Biol. 157, 281\u2013287 (2007).","journal-title":"J. Struct. Biol."},{"key":"2349_CR66","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr. D"},{"key":"2349_CR67","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1107\/S1399004714021683","volume":"71","author":"A Brown","year":"2015","unstructured":"Brown, A. et al. Tools for macromolecular model building and refinement into electron cryo-microscopy reconstructions. Acta Crystallogr. D 71, 136\u2013153 (2015).","journal-title":"Acta Crystallogr. D"},{"key":"2349_CR68","doi-asserted-by":"crossref","first-page":"e17219","DOI":"10.7554\/eLife.17219","volume":"5","author":"RY Wang","year":"2016","unstructured":"Wang, R. Y. et al. Automated structure refinement of macromolecular assemblies from cryo-EM maps using Rosetta. eLife 5, e17219 (2016).","journal-title":"eLife"},{"key":"2349_CR69","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.str.2018.09.006","volume":"27","author":"B Frenz","year":"2019","unstructured":"Frenz, B. et al. Automatically fixing errors in glycoprotein structures with Rosetta. Structure 27, 134\u2013139.e3 (2019).","journal-title":"Structure"},{"key":"2349_CR70","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1107\/S0907444909042073","volume":"66","author":"VB Chen","year":"2010","unstructured":"Chen, V. B. et al. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr. D 66, 12\u201321 (2010).","journal-title":"Acta Crystallogr. D"},{"key":"2349_CR71","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/nmeth.3541","volume":"12","author":"BA Barad","year":"2015","unstructured":"Barad, B. A. et al. EMRinger: side chain-directed model and map validation for 3D cryo-electron microscopy. Nat. Methods 12, 943\u2013946 (2015).","journal-title":"Nat. Methods"},{"key":"2349_CR72","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1107\/S2059798319011471","volume":"75","author":"D Liebschner","year":"2019","unstructured":"Liebschner, D. et al. Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix. Acta Crystallogr. D 75, 861\u2013877 (2019).","journal-title":"Acta Crystallogr. D"},{"key":"2349_CR73","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/nsmb.3115","volume":"22","author":"J Agirre","year":"2015","unstructured":"Agirre, J. et al. Privateer: software for the conformational validation of carbohydrate structures. Nat. Struct. Mol. Biol. 22, 833\u2013834 (2015).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"2349_CR74","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/pro.3235","volume":"27","author":"TD Goddard","year":"2018","unstructured":"Goddard, T. D. et al. UCSF ChimeraX: Meeting modern challenges in visualization and analysis. Protein Sci. 27, 14\u201325 (2018).","journal-title":"Protein Sci"},{"key":"2349_CR75","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1107\/S0907444910048675","volume":"67","author":"TG Battye","year":"2011","unstructured":"Battye, T. G., Kontogiannis, L., Johnson, O., Powell, H. R. & Leslie, A. G. iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM. Acta Crystallogr. D 67, 271\u2013281 (2011).","journal-title":"Acta Crystallogr. D"},{"key":"2349_CR76","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1107\/S0907444913000061","volume":"69","author":"PR Evans","year":"2013","unstructured":"Evans, P. R. & Murshudov, G. N. How good are my data and what is the resolution? Acta Crystallogr. D 69, 1204\u20131214 (2013).","journal-title":"Acta Crystallogr. D"},{"key":"2349_CR77","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1107\/S0021889807021206","volume":"40","author":"AJ McCoy","year":"2007","unstructured":"McCoy, A. J. et al. Phaser crystallographic software. J. Appl. Crystallogr. 40, 658\u2013674 (2007).","journal-title":"J. Appl. Crystallogr."},{"key":"2349_CR78","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1107\/S0907444911001314","volume":"67","author":"GN Murshudov","year":"2011","unstructured":"Murshudov, G. N. et al. REFMAC5 for the refinement of macromolecular crystal structures. Acta Crystallogr. D 67, 355\u2013367 (2011).","journal-title":"Acta Crystallogr. D"},{"key":"2349_CR79","doi-asserted-by":"publisher","unstructured":"Lam, T. T. et al. Identifying SARS-CoV-2-related coronaviruses in Malayan pangolins. Nature https:\/\/doi.org\/10.1038\/s41586-020-2169-0 (2020).","DOI":"10.1038\/s41586-020-2169-0"}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-020-2349-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-020-2349-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-020-2349-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T15:04:05Z","timestamp":1732806245000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-020-2349-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,18]]},"references-count":79,"journal-issue":{"issue":"7815","published-print":{"date-parts":[[2020,7,9]]}},"alternative-id":["2349"],"URL":"https:\/\/doi.org\/10.1038\/s41586-020-2349-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.04.07.023903","asserted-by":"object"}],"has-review":[{"id-type":"doi","id":"10.3410\/f.737968680.793576966","asserted-by":"object"}]},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,18]]},"assertion":[{"value":"6 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.P., S.B., K.C., E.C., C.H.-D., G.S., M.B., A.K., K.F., A.P., F.Z., S.J., B.G., A.D.M., A.L., A.T., H.W.V., R.S. and D.C. are employees of Vir Biotechnology and may hold shares in Vir Biotechnology. M.S.D. is a consultant for Inbios, Eli Lilly, Vir Biotechnology, NGM Biopharmaceuticals and Emergent BioSolutions, and on the Scientific Advisory Board of Moderna. The Diamond laboratory at Washington University School of Medicine has received sponsored research agreements from Moderna. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}